COMMUNIQUÉS West-GlobeNewswire

Delcath Announces Commencement of Rights Offering Subscription Period

06/08/2018 - 14:00

NEW YORK, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces the subscription period for [...]

Rexahn Reports Second Quarter 2018 Financial Results

06/08/2018 - 14:00

ROCKVILLE, Md., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, [...]

Fortress Biotech Announces Aevitas Therapeutics Enters Sponsored Research Agreement with the University of Pennsylvania to Advance AAV Gene Therapy Technology

06/08/2018 - 14:00

Agreement drives further testing of Aevitas’ AAV gene therapy technology in animal models of complement-mediated diseases NEW YORK, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Fortress Biotech (NASDAQ:FBIO) (“Fortress”), a [...]

BioSig Technologies Added to LD Micro Index

06/08/2018 - 14:00

Santa Monica, CA, Aug. 06, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. ( BSGM ), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology [...]

TG Therapeutics, Inc. to Host Conference Call on Second Quarter 2018 Financial Results and Business Update

06/08/2018 - 13:30

Investor Conference Call to be tomorrow, Tuesday, August 7, 2018 at 4:30pm ET NEW YORK, Aug. 06, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that a conference call will be held [...]

Indication for Use of SAVI SCOUT® Wire-Free Radar Breast Localization System Expands to Include Localization of Soft Tissue

06/08/2018 - 13:30

The SCOUT reflector can now be used to mark soft tissue sites including lymph nodes ALISO VIEJO, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cianna Medical, Inc., the world leader in wire-free breast localization, [...]

VIVUS Appoints Kenneth Suh as President

06/08/2018 - 13:30

CAMPBELL, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical company, today announced the appointment of Ken Suh to the position of President. Previously, Mr. Suh [...]

Otonomy Announces OTIPRIO® Co-Promotion Agreement with Mission Pharmacal for Acute Otitis Externa Indication

06/08/2018 - 13:30

SAN DIEGO, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced the signing of a co-promotion [...]

AMAG Pharmaceuticals Appoints Brian Robinson, M.D. as Senior Vice President of Medical Affairs

06/08/2018 - 13:30

WALTHAM, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced the appointment of Brian Robinson, M.D. as senior vice president, medical affairs, reporting into Julie Krop, M. [...]

Kiniksa Reports Second Quarter 2018 Financial Results and Pipeline Progress

06/08/2018 - 13:30

– Rilonacept advancing toward pivotal Phase 3 clinical trial in 2H 2018 following recent End-of-Phase 2 communication with FDA – – KPL-716 single-dose Phase 1a/1b Last Subject Last Visit achieved; clinical trial data [...]

Ovid Therapeutics Announces Positive Topline Data from Phase 2 STARS Trial of OV101 for the Treatment of Angelman Syndrome

06/08/2018 - 13:01

-- OV101 achieved primary endpoint of safety and tolerability -- -- Robust and statistically significant improvement (p=0.0006) in the first prespecified efficacy endpoint (CGI-I) observed at 12 weeks of treatment in [...]

miRagen Therapeutics and The Leukemia & Lymphoma Society® Enter Into an Agreement to Facilitate the Development of Cobomarsen in Cutaneous T-Cell Lymphoma

06/08/2018 - 13:00

BOULDER, Colo. and RYE BROOK, N.Y., Aug. 06, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted [...]

Cara Therapeutics Appoints Christopher A. Posner to Board of Directors

06/08/2018 - 13:00

STAMFORD, Conn., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and [...]

Elite Pharmaceuticals Receives FDA Approval for Generic Methadone Hydrochloride Tablets

06/08/2018 - 13:00

NORTHVALE, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]

Antares Pharma Enters Into Development Agreement With Pfizer Inc.

06/08/2018 - 13:00

EWING, N.J., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) today announced that it has entered into an agreement with Pfizer Inc. (“Pfizer”) to develop a combination drug device [...]

Neuralstem Appoints Jim Scully as Interim Chief Executive Officer

06/08/2018 - 13:00

William Oldaker Expands Role and is Named Chairman of the Board GERMANTOWN, Md., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system [...]

iTeos Therapeutics to Participate in Upcoming U.S. Conferences in August

06/08/2018 - 13:00

iTeos Therapeutics to Participate in Upcoming U.S. Conferences in August Gosselies, Belgium – August 6, 2018 – iTeos Therapeutics SA, a biotechnology company developing novel cancer immunotherapies, today announced that [...]

Complete Response Letter Issued for REMOXY™

06/08/2018 - 13:00

- Corporate Reorganization Expected Shortly - AUSTIN, Texas, Aug. 06, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE) today announced it had received a Complete Response Letter (CRL) from the U.S. Food [...]

Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations Form Partnership to Develop a Novel Gene Therapy Treatment for Cystic Fibrosis

06/08/2018 - 13:00

Oxford BioMedica, UK Cystic Fibrosis Gene Therapy Consortium, Boehringer Ingelheim and Imperial Innovations Form Partnership to Develop a Novel Gene Therapy Treatment for Cystic Fibrosis Oxford, UK – 6 August 2018: [...]